Deutsch English Français

Contact

EP1521570

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1521570

EP1521570 - ORAL DOSAGE FORM COMPRISING A LIQUID ACTIVE AGENT FORMULATION AND CONTROLLING RELEASE THEREOF BY AN EXPANDABLE OSMOTIC COMPOSITION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 09.10.2009 Database last updated on 24.04.2024
Most recent event Tooltip	13.11.2009	Change - representative	published on 16.12.2009 [2009/51]
Applicant(s)	For all designated states ALZA Corporation One Johnson & Johnson Plaza, WH 3221 New Brunswick, NJ 08933 / US
	[N/P]
Former [2005/15]	For all designated states Alza Corporation, c/o Johnson & Johnson One Johnson & Johnson Plaza, WH 3221 New Brunswick, NJ 08933 / US
Inventor(s)	01 / DONG, Liang-Chang 181 Leota Avenue Sunnyvale, CA 94086 / US
	02 / SHAFI, Keru 50 Amador Village 13 Hayward, CA 94544 / US
	03 / YUM, Alicia 2625 Carlmont Drive Belmont, CA 94002 / US
	04 / WONG, Patrick, S., L. 1533 Burlingame Avenue Burlingame, CA 94010 / US
	[2007/32]
Former [2005/15]	01 / DONG, Liang-Chang 181 Leota Avenue Sunnyvale, CA 94086 / US
	02 / SHAFI, Keru 50 Amador Village #13 Hayward, CA 94544 / US
	03 / YUM, Alicia 2625 Carlmont Drive Belmont, CA 94002 / US
	04 / WONG, Patrick, S., L. 1533 Burlingame Avenue Burlingame, CA 94010 / US
Representative(s)	Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2009/51]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Former [2005/15]	Mercer, Christopher Paul, et al Carpmaels & Ransford, 43-45 Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	03739346.9	27.06.2003
	[2005/15]
	WO2003US20422
Priority number, date	US20020392774P	28.06.2002 Original published format: US 392774 P
	[2005/15]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004002448
	Date:	08.01.2004
	Language:	EN
	[2004/02]
	Type:	A1 Application with search report
	No.:	EP1521570
	Date:	13.04.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 08.01.2004 takes the place of the publication of the European patent application.
	[2005/15]
Search report(s)	International search report - published on:	EP	08.01.2004
Classification	IPC:	A61K9/00, A61K9/48, A61K31/167, A61K31/57	[2005/15]
	CPC:	A61K31/57 (EP,US); A61K31/167 (EP,US); A61K9/0004 (EP,US); A61K9/48 (KR)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/15]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	ORALE DOSISFORM, DIE EINE FLÜSSIGE FORMULIERUNG EINES WIRKSTOFFES ENTHÄLT UND DESSEN KONTROLLIERTE FREISETZUNG ÜBER EINE ERWEITERUNGSFÄHIGE OSMOTISCHE ZUSAMMENSETZUNG GESTEUERT WIRD	[2008/46]
	English:	ORAL DOSAGE FORM COMPRISING A LIQUID ACTIVE AGENT FORMULATION AND CONTROLLING RELEASE THEREOF BY AN EXPANDABLE OSMOTIC COMPOSITION	[2005/15]
	French:	FORME POSOLOGIQUE ORALE COMPRENANT UNE PREPARATION DE PRINCIPE ACTIF LIQUIDE ET LIBERATION PROLONGEE DE CELLE-CI PAR L'INTERMEDIAIRE D'UNE COMPOSITION OSMOTIQUE EXPANSIBLE	[2005/15]
	Former [2005/15]	ORALE DOSISFORM, DIE EINE FLÜSSIGE FORMULIERUNG EINES WIRKSTOFFES ENTHÄLT UND DESSEN FREISETZUNG ÜBER EINE ERWEITERUNGSFÄHIGE OSMOSEZUSAMMENSETZUNG STEUERT
Entry into regional phase	27.01.2005	National basic fee paid
	27.01.2005	Designation fee(s) paid
	27.01.2005	Examination fee paid
Examination procedure	27.01.2004	Request for preliminary examination filed International Preliminary Examining Authority: EP
	27.01.2005	Examination requested [2005/15]
	02.01.2007	Despatch of a communication from the examining division (Time limit: M04)
	09.05.2007	Reply to a communication from the examining division
	05.12.2008	Communication of intention to grant the patent
	16.04.2009	Application deemed to be withdrawn, date of legal effect [2009/46]
	20.05.2009	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2009/46]
Fees paid	Renewal fee
	27.01.2005	Renewal fee patent year 03
	14.06.2006	Renewal fee patent year 04
	14.06.2007	Renewal fee patent year 05
	28.03.2008	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	30.06.2009	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[A]US4111202 (THEEUWES FELIX) [A] 1-36 * figure 6 * * column 8 - column 13, paragraph 58 * * claims 1,2,6,8-15,18,22-24 *;
		[A]US5034229 (MAGRUDER JUDY A [US], et al) [A] 1-36 * figures 5-11 * * column 6, line 50 - column 18, line 51 * * claims 1-4 *;
		[A]WO9820930 (ALZA CORP [US]) [A] 1-36 * claims 1-21 * * figure 1 * * page 5, line 9 - page 7, line 16 ** pages 11-17 *;
		[X]US5830502 (DONG LIANG C [US], et al) [X] 1-3,11-16,24-28,36 * columns 3-7 * * claims 1-8 * * claims 12-18 *;
		[XY]WO0013674 (ALZA CORP [US]) [X] 1-3,11-16,24-28,36 * page 9, line 18 - page 12, line 15 * * page 14, line 28 - page 16, line 27 * * claims 1-14 * * figures 2-4 * [Y] 1-36;
		[Y]WO0038655 (ALZA CORP [US], et al) [Y] 1-36 * figures 6,7 * * example 12 * * page 25, line 17 - line 21 * * page 26, line 20 - line 23 * * page 27, line 7 - line 32 * * pages 28-29 * * page 37, lines 9-32 * * page 38 - page 41, line 5 * * page 41, line 23 - page 45, line 18 * * page 47, line 10 - page 50, line 11 * * page 98, line 29 - page 106, line 10 * * page 108, line 14 - page 111, line 25 * * claims 41-53 *;
		[X]WO0141742 (ALZA CORP [US]) [X] 1,4-6,8-13,17-19,21-25,29-31,33-36 * claims 1-10,13,18-26 * * example 1 * * page 5, line 23 - page 6, line 26 * * page 7, line 29 - page 10 * * page 13, line 22 - page 21 *;
		[X]US2001036472 (WONG PATRICK S-L [US], et al) [X] 1,4-6,8-13,17-19,21-25,29-31,33-36 * claims 1-20 * * figures 2,7,10 * * paragraph [0031] - paragraph [0034] * * paragraph [0045] - paragraph [0064] * * paragraph [0070] - paragraph [0079] * * paragraph [0101] - paragraph [0102] *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p